XM does not provide services to residents of the United States of America.

Aviva posts 15% rise in 9-mth general insurance premiums



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Aviva posts 15% rise in 9-mth general insurance premiums</title></head><body>

Adds detail, background, CEO comment paragraphs 3-10

LONDON, Nov 14 (Reuters) -British insurer Aviva AV.L posted a 15% rise in general insurance gross written premiums for the first nine months of the year to 9.1 billion pounds ($11.54 billion) on Thursday and said it was confident of meeting its group targets.

The life, motor and home insurer, whose main businesses are in Britain, Canada and Ireland, also reported a 67% rise in retirement sales to 7.3 billion pounds, helped by strong performance in insurance for company definedbenefit pension schemes known as bulk annuities.

Insurers have made healthy profits in recent years, responding to higher inflation and losses from COVID-19 and natural catastrophes by raising premiums.

"Aviva is financially strong, trading well each quarter and has significant opportunities for further growth," Chief Executive Amanda Blanc said in a statement.

Aviva outlined group targets earlier this year, including 2 billion pounds in operating profit by 2026. Its 2023 profit was 1.47 billion pounds.

Aviva had a combined operating ratio in the first nine months of 96.8%, compared with 96.3% a year earlier. Combined operating ratio is a measure of underwriting profitability in which a level below 100% indicates a profit.

Aviva said its bulk annuity volumes were 6.1 billion pounds in the first nine months, compared with 3.2 billion a year ago. Aviva wrote 7.8 billion pounds in bulk deals by Thursday and said it did not expect volumes to increase materially for the rest of the year.

The UK bulk annuity market saw a record 50 billion pounds in deals last year, and industry sources expect a similar volume this year.

KBW analysts described the trading update as "reassuring", reiterating their "market perform" rating on the stock.




($1 = 0.7886 pounds)



Reporting by Carolyn Cohn, editing by Sinead Cruise

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.